Summary
An improved HPLC method with electrochemical detection has been developed for the determination of olanzapine and its main metabolite, desmethylolanzapine, in human plasma. Chromatographic separation and analysis were performed on a C8 reversed-phase column with a mixture of methanol, acetonitrile, and pH 3.7 phosphate buffer as mobile phase; 2-methylolanzapine was used as internal standard. Careful pretreatment of the plasma samples was implemented by means of solid phase extraction (SPE).
Response was linearly dependent on concentration and precision was satisfactory over the concentration range 0.5–75.0 ng mL−1 for both analytes. The limit of detection was 0.2 ng mL−1 for both analytes. Application to plasma samples of patients treated with Zyprexa tablets gave good results. Because of its sensitivity and selectivity, and the need for small plasma samples, this method seems to be a useful tool for clinical monitoring.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ring, B.J.; Catlow, J.; Lindsay, T.J.; Gillespie, T.; Roskos, L.K.; Cerimele, B.J.; Swanson, S.P.; Hamman, M.A.; Wrighton, S.A.J. Pharmacol. Exp. Ther. 1996,276, 658–666.
Callaghan, J.T.; Bergstrom, R.F.; Ptak, L.R.; Beasley, C.M.Clin. Pharmacokinet. 1999,37, 177–193.
Bogusz, M.J.; Krüger, K.D.; Maier, R.D.; Erkwoh, R.; Tuchtenhagen, F.J. Chromatogr. B 1999,732, 257–269.
Fulton, B.; Goa, K.L.Drugs 1997,53, 281–298.
Catlow, J.T.; Barton, R.D.; Clemens, M.; Gillespie, T.A.; Goodwin, M.; Swanson S.P.J. Chromatogr. B 1995,668, 85–90.
Olesen, O.V.; Linnett, K.J. Chromatogr. B1998,714, 309–315.
Kasper, S.C.; Mattiuz, E.L.; Swanson, S.P.; Chiu, J.A.; Johnson, J.T.; Garner, C.O.,J. Chromatogr. B,1999,726, 203–209.
Aravagiri, M.; Ames, D.; Wirshing, W.C.; Marder, S.R.Ther. Drug Monit. 1997,19, 307–313.
Xue, L.; Crookham, S.B.; Diamond, F.X.; Davis, D.J.; Reiber, T.M.Clin. Chem. 1998,44, 450–460.
Jenkins, A.J.; Sarconi, K.M.; Raaf, H.N.J. Anal. Toxicol. 1998,22, 605–609.
Berna, M.; Shugert, R.; Mullen, J.J. Mass Spectrom. 1998,33, 1003–1008.
Chiu, J.A.; Franklin, R.B.J. Pharm. Biomed. Anal. 1996,14, 609–615.
Raggi, M.A.; Casamenti, G.; Mandrioli, R.; Fanali, S.; De Ronchi, D.; Volterra, V.Chromatographia,2000,51, 562–566.
Raggi, M.A.; Casamenti, G.; Mandrioli, R.; Volterra, V.J. Chromatogr. B,2001,750, 137–146.
Raggi, M.A.; Casamenti, G.; Mandrioli, R.; Izzo, G.; Kenndler, E.J. Pharm. Biomed. Anal. 2000,23, 973–981.
Shah, V.P.; Midha, K.K.; Dighe, S.; McGilveray, I.J.; Skelly, J.P.; Yacobi, A.; Layloff, T.; Viswanathan, C.T.; Cook, C.E.; McDowall, R.D.; Pittman, K.A.; Spector, S.Pharm. Res.,1992,9, 588–592.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Raggi, M.A., Mandrioli, R., Sabbioni, C. et al. Determination of olanzapine and desmethylolanzapine in the plasma of schizophrenic patients by means of an improved HPLC method with amperometric detection. Chromatographia 54, 203–207 (2001). https://doi.org/10.1007/BF02492246
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02492246